Particularly, ECs from glioma exclusively expressed a series of transmembrane transport-associated genes, including SLC2A1, BSG, SLC7A1, and SLC7A5, suggesting that ECs in brain tumors were still involved in retaining the brain-blood barrier. Here, SLC2A1 is linked to central nervous system cancer.